Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX

New England Journal of Medicine

Volumn 358, Issue 9, 2008, Pages 900-909

  Hom, Geoffrey ^a   Graham, Robert R ^a   Modrek, Barmak ^a   Taylor, Kimberly E ^b   Ortmann, Ward ^a   Garnier, Sophie ^c   Lee, Annette T ^d   Chung, Sharon A ^b   Ferreira, Ricardo C ^a   Pant, P V Krishna ^e   Ballinger, Dennis G ^e   Kosoy, Roman ^f   Demirci, F Yesim ^g   Kamboh, M Ilyas ^g   Kao, Amy H ^g   Tian, Chao ^f   Gunnarsson, Iva ^h   Bengtsson, Anders A ⁱ   Rantapää Dahlqvist, Solbritt ^j   Petri, Michelle ^k   Manzi, Susan ^g   Seldin, Michael F ^f   Rönnblom, Lars ^c   Syvänen, Ann Christine ^c   Criswell, Lindsey A ^b   Gregersen, Peter K ^d   Behrens, Timothy W ^a   more..

^a GENENTECH INC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UPPSALA UNIVERSITY   (Sweden)

^d FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^e Perlegen Sciences Inc   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^h KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

ⁱ LUND UNIVERSITY HOSPITAL   (Sweden)

^j UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^k JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA X INTEGRIN; B LYMPHOID TYROSINE KINASE; CD11B ANTIGEN; DNA; INTEGRIN; MESSENGER RNA; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; ITGAM PROTEIN, HUMAN;

ARTICLE; B LYMPHOCYTE; CHROMOSOME 16P; CHROMOSOME 8P; CONTROLLED STUDY; DNA DETERMINATION; DNA REPLICATION; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC CODE; GENETIC DATABASE; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; OPEN READING FRAME; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROMOTER REGION; QUALITY CONTROL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SWEDEN; SYSTEMIC LUPUS ERYTHEMATOSUS; UNITED STATES; CASE CONTROL STUDY; GENETICS; GENOME; METABOLISM; NORTH AMERICA;

ANTIGENS, CD11B; B-LYMPHOCYTES; CASE-CONTROL STUDIES; GENOME, HUMAN; GENOTYPE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; NORTH AMERICA; POLYMORPHISM, SINGLE NUCLEOTIDE; SRC-FAMILY KINASES; SWEDEN;

EID: 40049108936     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa0707865     Document Type: Article

References (49)

1. Hochberg MC. The epidemiology of systemic lupus erythematosus. In: Wallace DJ, Hahn BH, eds. Dubois' lupus erythematosus. 5th ed. Baltimore: Williams & Wilkins, 1997:49-65.
2. Wakeland EK, Liu K, Graham RR, Behrens TW. Delineating the genetic basis of systemic lupus erythematosus. Immunity 2001;15:397-408.
3. Nath SK, Kilpatrick J, Harley JB. Genetics of human systemic lupus erythematosus: the emerging picture. Curr Opin Immunol 2004;16:794-800.
4. Goldberg MA, Arnett FC, Bias WB, Shulman LE. Histocompatibility antigens in systemic lupus erythematosus. Arthritis Rheum 1976;19:129-32.
5. Graham RR, Ortmann WA, Langefeld CD, et al. Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. Am J Hum Genet 2002;71:543-53.
6. Graham RR, Ortmann W, Rodine P, et al. Specific combinations of HLA-DR2 and DR3 class II haplotypes contribute graded risk for disease susceptibility and autoantibodies in human SLE. Eur J Hum Genet 2007;15:823-30.
7. Sigurdsson S, Nordmark G, Göring HH, et al. Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet 2005;76:528-37.
8. Graham RR, Kozyrev SV, Baechler EC, et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 2006;38:550-5.
9. Graham RR, Kyogoku C, Sigurdsson S, et al. Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc Natl Acad Sci U S A 2007;104:6758-63.
10. Remmers EF, Plenge RM, Lee AT, et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 2007;357:977-86.
11. Rönnblom L, Alm GV. A pivotal role for the natural interferon alpha-producing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus. J Exp Med 2001;194:F59-F63.
12. Baechler EC, Gregersen PK, Behrens TW. The emerging role of interferon in human systemic lupus erythematosus. Curr Opin Immunol 2004;16:801-7.
13. Banchereau J, Pascual V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 2006;25:383-92.
14. Miyagi T, Gil MP, Wang X, Louten J, Chu WM, Biron CA. High basal STAT4 balanced by STAT1 induction to control type 1 interferon effects in natural killer cells. J Exp Med 2007;204:2383-96.
15. Bauer JW, Baechler EC, Petri M, et al. Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus. PLoS Med 2006;3(12):e491.
16. Criswell LA, Pfeiffer KA, Lum RF, et al. Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet 2005;76:561-71.
17. Seligman VA, Suarez C, Lum R, et al. The Fcgamma receptor IIIA-158F allele is a major risk factor for the development of lupus nephritis among Caucasians but not non-Caucasians. Arthritis Rheum 2001;44:618-25.
18. Demirci FY, Manzi S, Ramsey-Goldman R, et al. Association of a common interferon regulatory factor 5 (IRF5) variant with increased risk of systemic lupus erythematosus (SLE). Ann Hum Genet 2007;71:308-11.
19. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
20. Mitchell MK, Gregersen PK, Johnson S, Parsons R, Vlahov D. The New York Cancer Project: rationale, organization, design, and baseline characteristics. J Urban Health 2004;81:301-10.
21. Gunderson KL, Steemers FJ, Ren H, et al. Whole-genome genotyping. Methods Enzymol 2006;410:359-76.
22. Hsu TM, Chen X, Duan S, Miller RD, Kwok PY. Universal SNP genotyping assay with fluorescence polarization detection. Biotechniques 2001;31:560, 562, 564-8.
23. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006;38:904-9.
24. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559-75.
25. Stranger BE, Nica AC, Forrest MS, et al. Population genomics of human gene expression. Nat Genet 2007;39:1217-24.
26. Dixon AL, Liang L, Moffatt MF, et al. A genome-wide association study of global gene expression. Nat Genet 2007;39:1202-7.
27. Devlin B, Roeder K, Wasserman L. Genomic control for association studies: a semiparametric test to detect excess-haplotype sharing. Biostatistics 2000;1:369-87.
28. de Bakker PI, McVean G, Sabeti PC, et al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet 2006;38:1166-72.
29. Giglio S, Broman KW, Matsumoto N, et al. Olfactory receptor-gene clusters, genomic-inversion polymorphisms, and common chromosome rearrangements. Am J Hum Genet 2001;68:874-83.
30. Sugawara H, Harada N, Ida T, et al. Complex low-copy repeats associated with a common polymorphic inversion at human chromosome 8p23. Genomics 2003;82:238-44.
31. Hirschhorn JN, Daly MJ. Genomewide association studies for common diseases and complex traits. Nat Rev Genet 2005;6:95-108.
32. Cheung VG, Spielman RS, Ewens KG, Weber TM, Morley M, Burdick JT. Mapping determinants of human gene expression by regional and genome-wide association. Nature 2005;437:1365-9.
33. Dymecki SM, Zwollo P, Zeller K, Kuhajda FP, Desiderio SV. Structure and developmental regulation of the B-lymphoid tyrosine kinase gene blk. J Biol Chem 1992;267:4815-23.
34. Wasserman R, Li YS, Hardy RR. Differential expression of the blk and ret tyrosine kinases during B lineage development is dependent on Ig rearrangement. J Immunol 1995;155:644-51.
35. Texido G, Su IH, Mecklenbräuker I, et al. The B-cell-specific Src-family kinase Blk is dispensable for B-cell development and activation. Mol Cell Biol 2000;20:1227-33.
36. Tsukada S, Saffran DC, Rawlings DJ, et al. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 1993;72:279-90.
37. Khan WN, Alt FW, Gerstein RM, et al. Defective B cell development and function in Btk-deficient mice. Immunity 1995;3:283-99.
38. Cornall RJ, Goodnow CC. B cell antigen receptor signalling in the balance of tolerance and immunity. Novartis Found Symp 1998;215:21-30.
39. Nemazee D, Weigert M. Revising B cell receptors. J Exp Med 2000;191:1813-7.
40. Kumar KR, Li L, Yan M, et al. Regulation of B cell tolerance by the lupus susceptibility gene Ly108. Science 2006;312:1665-9.
41. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992;69:11-25.
42. Lu H, Smith CW, Perrard J, et al. LFA-1 is sufficient in mediating neutrophil emigration in Mac-1-deficient mice. J Clin Invest 1997;99:1340-50.
43. Abbas AR, Baldwin D, Ma Y, et al. Immune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data. Genes Immun 2005;6:319-31.
44. Dunne JL, Collins RG, Beaudet AL, Ballantyne CM, Ley K. Mac-1, but not LFA-1, uses intercellular adhesion molecule-1 to mediate slow leukocyte rolling in TNF-alpha-induced inflammation. J Immunol 2003;171:6105-11.
45. Hammerberg C, Katiyar SK, Carroll MC, Cooper KD. Activated complement component 3 (C3) is required for ultraviolet induction of immunosuppression and antigenic tolerance. J Exp Med 1998;187:1133-8.
46. Sohn JH, Bora PS, Suk HJ, Molina H, Kaplan HJ, Bora NS. Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells. Nat Med 2003;9:206-12.
47. Watts GM, Beurskens FJ, Martin-Padura I, et al. Manifestations of inflammatory arthritis are critically dependent on LFA-1. J Immunol 2005;174:3668-75.
48. Ehirchiou D, Xiong Y, Xu G, Chen W, Shi Y, Zhang L. CD11b facilitates the development of peripheral tolerance by suppressing Th17 differentiation. J Exp Med 2007;204:1519-24.
49. Buyon JP, Shadick N, Berkman R, et al. Surface expression of Gp 165/95, the complement receptor CR3, as a marker of disease activity in systemic lupus erythematosus. Clin Immunol Immunopathol 1988;46:141-9.